We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTemozolomide as second or third line treatment of patients with neuroendocrine carcinomas.AuthorsOlsen IH; Sørensen JB; Federspiel B; Kjaer A; Hansen CP; Knigge U; Langer SWPublicationTheScientificWorldJournal, 2012, Vol 2012, p170496ISSN1537-744xPublication typearticleDOI10.1100/2012/170496